![]() |
市场调查报告书
商品编码
1744638
2032 年抗坏血酸市场预测:依原料、形式、等级、通路、製造流程、包装及地区进行的全球分析Ascorbic Acid Market Forecasts to 2032 - Global Analysis By Source (Synthetic and Natural), Form (Powder, Granules, Tablets, Capsules and Other Forms), Grade, Distribution Channel, Manufacturing Process, Packaging and By Geography |
根据 Stratistics MRC 的数据,全球抗坏血酸市场预计在 2025 年达到 17.1 亿美元,到 2032 年将达到 27.9 亿美元,预测期内的复合年增长率为 7.2%。
抗坏血酸,又称维生素C,是一种对人体健康至关重要的水溶性维生素。它对创伤治疗、胶原蛋白合成以及维持强壮的骨骼、软骨和皮肤至关重要。抗坏血酸无法由人体自然合成,必须透过饮食或补充剂来取得。抗坏血酸存在于甜椒、柳橙和草莓等水果和蔬菜中,它能促进铁的吸收,增强免疫系统功能,对整体健康至关重要。
据CXO称,食品级抗坏血酸的需求每年增长约5%,因此引入新的抗坏血酸製造流程可望协助弥补供需缺口。
机能性食品和食品饮料的成长
抗坏血酸因其增强免疫力和抗氧化特性而广受欢迎,消费者正在寻求能够提供超越基本营养补充剂的健康益处的产品。由于其公认的健康益处,抗坏血酸常用于强化饮料、点心和补充剂。维生素C对于增强机能饮料的吸引力和功效至关重要,尤其是在免疫力和健康领域。消费者对预防和健康的日益关注,促使製造商在其产品配方中添加抗坏血酸。因此,推动全球抗坏血酸市场扩张的主要因素之一是机能性食品和食品饮料的趋势。
原物料价格波动
山梨糖醇和玉米等必需品价格的定期波动会扰乱预算和供应链规划。这种不确定性会降低利润率,并阻碍扩大生产的投资。中小企业尤其面临风险,因为它们通常无法应对意外的支出成长。长期合约和客户关係也可能受到价格波动的影响。整体而言,市场变得不稳定,波动会减缓成长。
新兴国家的需求不断成长
维生素C在药品和膳食补充剂中的应用是都市化加快和医疗设施改善的结果。日益壮大的中产阶级人口的健康意识增强,推动了对强化食品和饮料的需求。巴西、中国和印度等国食品加工产业的成长也带动了抗坏血酸作为抗氧化剂和防腐剂的使用量增加。政府推出的提高营养素养的计画也促进了市场的扩张。总而言之,这显示新兴国家对抗坏血酸的需求持续旺盛。
仿冒品/不合格品
掺假和仿冒品往往不符合安全和功效要求,威胁消费者健康,并可能导致法律后果。仿冒品引发的价格上涨使合法企业难以公平竞争。为此,监管机构可能会实施更严格的监管规定,从而提高正规企业的合规成本。假冒产品的存在也会损害值得信赖的供应商的品牌声誉。最终,这会阻碍整体市场扩张,并抑制对新产品开发的投资。
COVID-19的影响
新冠疫情严重影响了抗坏血酸市场,由于其增强免疫力的特性,其需求量随之增长。消费者和医疗保健行业将维生素C优先用于预防和恢復,从而提振了其销售。然而,供应链中断和原材料短缺最初阻碍了生产和分销。随着市场逐渐适应,製造商扩大了产量以满足不断增长的需求。整体而言,疫情加速了人们对抗坏血酸的认知和消费,儘管初期面临挑战,但仍对市场成长产生了正面影响。
预计在预测期内合成部分将成为最大的部分。
预计合成产品将在预测期内占据最大的市场占有率,这得益于其经济高效且可扩展的生产流程。这使得大规模生产能够满足食品、药品和化妆品等行业日益增长的需求。合成抗坏血酸确保一致的纯度和稳定性,使其适用于工业应用。它还有助于延长保质期,并提高加工产品的配方适用性。此外,合成生产方法的持续创新有助于降低成本,进一步提升市场采用率。
预计在预测期内泡壳包装部分将以最高的复合年增长率成长。
泡壳包装领域预计将在预测期内实现最高成长率,这得益于其有效防潮防空气,从而提高产品稳定性并延长保质期。泡壳包装是一种方便的单份包装,它增加了消费者对维生素和补充剂的偏好,尤其是在药品和营养保健品领域。泡壳包装还能确保剂量精准和防窜改,增强消费者对抗坏血酸产品的信任。其经济高效且可扩展的特性吸引了那些希望提高包装效率的製造商。此外,泡壳包装美观的外观能够促进零售,进一步推动市场成长。
由于人口增长、都市化以及製药和食品加工行业的扩张,预计亚太地区将在预测期内占据最大的市场占有率。消费者对健康益处和预防保健意识的不断提高,推动了消费的成长。中国和印度凭藉其庞大的生产能力和不断增长的国内需求,成为主要贡献者。该市场的特点是生产成本低廉且出口不断成长。此外,政府促进营养和健康的倡议进一步刺激了成长,使亚太地区成为全球抗坏血酸市场成长最快的地区之一。
在预测期内,北美预计将呈现最高的复合年增长率,这得益于食品和饮料行业对维生素的需求不断增长,尤其是对其抗氧化特性和维生素补充剂的作用。日益增强的健康意识和膳食补充剂行业的扩张正在推动市场成长。主要企业正专注于技术创新和永续的生产方法,以满足严格的法规要求。製药和化妆品行业也在推动需求成长。北美拥有成熟的供应链和先进的製造设施,在消费者对天然成分和强化产品的偏好的推动下,市场保持着稳定的成长轨迹。
According to Stratistics MRC, the Global Ascorbic Acid Market is accounted for $1.71 billion in 2025 and is expected to reach $2.79 billion by 2032 growing at a CAGR of 7.2% during the forecast period. A water-soluble vitamin that is vital to human health is ascorbic acid, also referred to as vitamin C. As a potent antioxidant, it shields cells from harm brought on by free radicals. It is essential for wound healing, collagen synthesis, and the preservation of strong bones, cartilage, and skin. Ascorbic acid must be obtained through diet or supplements because humans are unable to make it naturally. Ascorbic acid, which is present in fruits and vegetables such as bell peppers, oranges, and strawberries, is essential for overall health since it boosts iron absorption and immune system performance.
According to CXOs, the introduction of a new production process for ascorbic acid is expected to close down the demand and supply gap, as every year the demand for food-grade ascorbic acid rises by ~5%.
Growth in functional foods and beverages
Ascorbic acid is a common ingredient because of its immune-boosting and antioxidant qualities, and consumers are looking for goods that provide health advantages beyond basic nutrition. Because of its well-established health benefits, ascorbic acid is frequently used to fortify beverages, snacks, and supplements. Vitamin C is very necessary for functional beverages to increase their attractiveness and effectiveness, particularly in the immunity and wellness categories. Manufacturers are adding more ascorbic acid to product formulations as a result of consumers' increased emphasis on prevention and health. Consequently, one of the main factors propelling the expansion of the worldwide ascorbic acid market is the trend towards functional foods and beverages.
Raw material price volatility
Regular changes in the cost of essential inputs, such as sorbitol and maize, interfere with budgeting and supply chain planning. These ambiguities have the potential to lower profit margins and deter investment in expanding production. Small and mid-sized businesses are particularly at risk since they frequently can't keep up with unexpected expense rises. Long-term agreements and client relationships may also be impacted by inconsistent pricing. In general, market stability is compromised and growth is slowed by volatility.
Rising demand in emerging economies
Increased use of vitamin C in medications and nutritional supplements is a result of growing urbanisation and better healthcare facilities. The demand for fortified foods and beverages is being driven by growing middle-class populations that are growing more health conscious. Growing food processing industries in nations like Brazil, China, and India also lead to a rise in the use of ascorbic acid as an antioxidant and preservative. Government programs that raise knowledge of nutrition also help the market expand. All things considered, these elements contribute to the high and ongoing need for ascorbic acid in emerging nations.
Counterfeit and substandard products
Products that are subpar and counterfeit frequently fall short of safety and effectiveness requirements, endangering consumer health and perhaps resulting in legal repercussions. Because of price undercutting caused by their dissemination, it is more difficult for legitimate firms to engage in fair competition. In response, regulatory agencies might impose more stringent guidelines, raising the cost of compliance for respectable businesses. The reputation of reliable providers' brands is also harmed by the existence of counterfeit goods. In the end, this hinders market expansion generally and deters investment in new product development.
Covid-19 Impact
The Covid-19 pandemic significantly impacted the ascorbic acid market by driving increased demand due to its immune-boosting properties. Consumers and healthcare sectors prioritized vitamin C for prevention and recovery, boosting sales. However, supply chain disruptions and raw material shortages initially hindered production and distribution. As the market adapted, manufacturers scaled up output to meet rising demand. Overall, the pandemic accelerated awareness and consumption of ascorbic acid, positively influencing market growth despite early challenges.
The synthetic segment is expected to be the largest during the forecast period
The synthetic segment is expected to account for the largest market share during the forecast period, due to its cost-effective and scalable production process. It enables mass manufacturing to meet growing demand across industries like food, pharmaceuticals, and cosmetics. Synthetic ascorbic acid ensures consistent purity and stability, making it preferable for industrial applications. It also supports longer shelf life and better formulation compatibility in processed products. Additionally, ongoing innovations in synthetic production methods help lower costs, further boosting market adoption.
The blister packs segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the blister packs segment is predicted to witness the highest growth rate by enhancing product stability and extending shelf life through effective protection from moisture and air. These packs offer convenient, single-dose packaging, increasing consumer preference for vitamins and supplements, especially in the pharmaceutical and nutraceutical sectors. Blister packaging also ensures accurate dosing and tamper resistance, boosting consumer confidence in ascorbic acid products. Its cost-effective and scalable nature appeals to manufacturers looking to improve packaging efficiency. Moreover, the visually appealing presentation of blister packs helps drive retail sales, further supporting market growth.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising population, urbanization, and expanding pharmaceutical and food processing industries. Increasing consumer awareness about health benefits and preventive healthcare is driving higher consumption. China and India are major contributors due to their large-scale production capabilities and growing domestic demand. The market is characterized by cost-effective manufacturing and expanding exports. Additionally, government initiatives promoting nutrition and wellness further stimulate growth, making Asia Pacific one of the fastest-growing regions in the global Ascorbic Acid market.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR by increasing demand from the food and beverage sector, especially for its antioxidant properties and role as a vitamin supplement. Rising health consciousness and the expanding nutraceutical industry contribute to market growth. Key players focus on innovation and sustainable production methods to meet stringent regulations. The pharmaceutical and cosmetic industries also bolster demand. With well-established supply chains and advanced manufacturing facilities, North America maintains a steady market trajectory, supported by consumer preference for natural and fortified products.
Key players in the market
Some of the key players profiled in the Ascorbic Acid Market include BASF, CSPC Weisheng Pharmaceutical, Honson Pharmatech Group, Microvi Biotech Inc., MEDISCA, Reckon Organics Pvt. Ltd., DSM Nutritional Products, Anhui Minmetals Development Co., Ltd., Northeast Pharmaceutical Group Co., Ltd., Hebei Welcome Pharmaceutical Co., Ltd., Zhejiang NHU Co., Ltd., Wuhan NHU Co., Ltd., FINE USA, Inc., Zhejian Medicine Co., Ltd., Shijiazhuang No.4 Pharmaceutical Co., Ltd., Wuhan Zhongxin Biological Pharmaceutical Co., Ltd., Hangzhou Hestar Biotech Co., Ltd. and Zhucheng Tongda Chemical Co., Ltd.
In November 2024, BASF partnered with Acies Bio to develop sustainable fermentation technologies for producing fatty alcohols, essential in personal and home care products. This collaboration aims to utilize Acies Bio's OneCarbonBio platform for efficient conversion of renewable methanol into chemical raw materials.
In January 2024, CSPC Innovation Pharmaceutical Co., Ltd. agreed to acquire CSPC Baike Biopharmaceutical Co., Ltd. from CSPC Weisheng Pharmaceutical and other CSPC entities for CNY 9.8 billion. This deal was aimed at consolidating CSPC's innovative drug pipeline and strengthening its core business, including health food and functional raw materials, which are closely tied to the ascorbic acid market
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.